Shawn Singh insider trades

Open-market stock purchases and sales by Shawn Singh, President and CEO at Vistagen Therapeutics, Inc, from SEC Form 4 filings since May 11, 2011.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +40%.

Recent trades

DateStockTradeValue
Apr 7, 2026VTGN Vistagen Therapeutics, IncBought (not open market)—
Apr 7, 2026VTGN Vistagen Therapeutics, IncBought (not open market)—

Companies traded

  • VTGN Vistagen Therapeutics, Inc: 1 buy, last Apr 7, 2026
  • VSTA VistaGen Therapeutics, Inc: other filings, last Feb 12, 2016
  • EXCA Excaliber Enterprises, Ltd: other filings, last May 11, 2011

Get free alerts when Shawn Singh files a new trade →